DK0673931T3 - Sulfonamidocarbonylpyridin-2-carboxylsyreamider samt deres pyridin-N-oxider, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel - Google Patents
Sulfonamidocarbonylpyridin-2-carboxylsyreamider samt deres pyridin-N-oxider, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddelInfo
- Publication number
- DK0673931T3 DK0673931T3 DK95103581.5T DK95103581T DK0673931T3 DK 0673931 T3 DK0673931 T3 DK 0673931T3 DK 95103581 T DK95103581 T DK 95103581T DK 0673931 T3 DK0673931 T3 DK 0673931T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- opt
- bond
- substd
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4410423A DE4410423A1 (de) | 1994-03-25 | 1994-03-25 | Sulfonamidocarbonylpyridin-2-carbonsäureamide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0673931T3 true DK0673931T3 (da) | 1998-03-16 |
Family
ID=6513863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95103581.5T DK0673931T3 (da) | 1994-03-25 | 1995-03-13 | Sulfonamidocarbonylpyridin-2-carboxylsyreamider samt deres pyridin-N-oxider, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5610172A (fi) |
| EP (1) | EP0673931B1 (fi) |
| JP (1) | JPH07278109A (fi) |
| KR (1) | KR950032124A (fi) |
| CN (1) | CN1114312A (fi) |
| AT (1) | ATE156815T1 (fi) |
| AU (1) | AU689199B2 (fi) |
| CA (1) | CA2145476A1 (fi) |
| CZ (1) | CZ287768B6 (fi) |
| DE (2) | DE4410423A1 (fi) |
| DK (1) | DK0673931T3 (fi) |
| ES (1) | ES2105798T3 (fi) |
| FI (1) | FI951386A (fi) |
| GR (1) | GR3024860T3 (fi) |
| HK (1) | HK1012338A1 (fi) |
| HU (1) | HUT72059A (fi) |
| NO (1) | NO304308B1 (fi) |
| NZ (1) | NZ270783A (fi) |
| PL (1) | PL180042B1 (fi) |
| ZA (1) | ZA952408B (fi) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6191368B1 (en) | 1995-09-12 | 2001-02-20 | Tessera, Inc. | Flexible, releasable strip leads |
| EP2295060B1 (en) | 2001-12-06 | 2018-10-31 | Fibrogen, Inc. | Treatment or prevention of ischemic or hypoxic conditions |
| CN1602360A (zh) * | 2001-12-06 | 2005-03-30 | 法布罗根股份有限公司 | 提高内源性红细胞生成素(epo)的方法 |
| US20040158289A1 (en) * | 2002-11-30 | 2004-08-12 | Girouard Steven D. | Method and apparatus for cell and electrical therapy of living tissue |
| US8124582B2 (en) * | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
| US7618940B2 (en) * | 2002-12-06 | 2009-11-17 | Fibrogen, Inc. | Fat regulation |
| US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| US7840263B2 (en) * | 2004-02-27 | 2010-11-23 | Cardiac Pacemakers, Inc. | Method and apparatus for device controlled gene expression |
| US7764995B2 (en) * | 2004-06-07 | 2010-07-27 | Cardiac Pacemakers, Inc. | Method and apparatus to modulate cellular regeneration post myocardial infarct |
| US7729761B2 (en) * | 2004-07-14 | 2010-06-01 | Cardiac Pacemakers, Inc. | Method and apparatus for controlled gene or protein delivery |
| US7828711B2 (en) * | 2004-08-16 | 2010-11-09 | Cardiac Pacemakers, Inc. | Method and apparatus for modulating cellular growth and regeneration using ventricular assist device |
| US7981065B2 (en) | 2004-12-20 | 2011-07-19 | Cardiac Pacemakers, Inc. | Lead electrode incorporating extracellular matrix |
| US8060219B2 (en) * | 2004-12-20 | 2011-11-15 | Cardiac Pacemakers, Inc. | Epicardial patch including isolated extracellular matrix with pacing electrodes |
| AU2006259352A1 (en) | 2005-06-15 | 2006-12-28 | Fibrogen, Inc. | Use of HIF 1alfa modulators for treatment of cancer |
| US7774057B2 (en) | 2005-09-06 | 2010-08-10 | Cardiac Pacemakers, Inc. | Method and apparatus for device controlled gene expression for cardiac protection |
| PL2008460T3 (pl) * | 2006-03-30 | 2017-10-31 | Lg Electronics Inc | Sposób i urządzenie do dekodowania/kodowania sygnału wideo |
| HUE041300T2 (hu) | 2006-06-26 | 2019-05-28 | Akebia Therapeutics Inc | Prolilhidroxiláz inhibitorok és alkalmazási eljárások |
| US8962530B2 (en) * | 2007-06-27 | 2015-02-24 | Regents Of The University Of Colorado | Inflammatory bowel disease therapies |
| NO2686520T3 (fi) | 2011-06-06 | 2018-03-17 | ||
| NZ714963A (en) | 2013-06-13 | 2020-07-31 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
| TWI665190B (zh) | 2013-11-15 | 2019-07-11 | 阿克比治療有限公司 | ｛［５－（３－氯苯基）－３－羥基吡啶－２－羰基］胺基｝乙酸之固體型式，其組合物及用途 |
| AU2016209126A1 (en) | 2015-01-23 | 2017-08-10 | Akebia Therapeutics, Inc. | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof |
| NZ773901A (en) | 2015-04-01 | 2024-07-26 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
| AU2019265629B2 (en) | 2018-05-09 | 2024-09-12 | Akebia Therapeutics, Inc. | Process for preparing 2-((5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl)amino)acetic acid |
| US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW352384B (en) * | 1992-03-24 | 1999-02-11 | Hoechst Ag | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals |
-
1994
- 1994-03-25 DE DE4410423A patent/DE4410423A1/de not_active Withdrawn
-
1995
- 1995-03-13 DK DK95103581.5T patent/DK0673931T3/da active
- 1995-03-13 EP EP95103581A patent/EP0673931B1/de not_active Expired - Lifetime
- 1995-03-13 DE DE59500488T patent/DE59500488D1/de not_active Expired - Fee Related
- 1995-03-13 AT AT95103581T patent/ATE156815T1/de not_active IP Right Cessation
- 1995-03-13 ES ES95103581T patent/ES2105798T3/es not_active Expired - Lifetime
- 1995-03-23 NZ NZ270783A patent/NZ270783A/en unknown
- 1995-03-23 CZ CZ1995733A patent/CZ287768B6/cs not_active IP Right Cessation
- 1995-03-23 FI FI951386A patent/FI951386A/fi unknown
- 1995-03-23 AU AU15042/95A patent/AU689199B2/en not_active Ceased
- 1995-03-24 PL PL95307848A patent/PL180042B1/pl unknown
- 1995-03-24 NO NO951146A patent/NO304308B1/no not_active IP Right Cessation
- 1995-03-24 CN CN95103572A patent/CN1114312A/zh active Pending
- 1995-03-24 HU HU9500865A patent/HUT72059A/hu unknown
- 1995-03-24 ZA ZA952408A patent/ZA952408B/xx unknown
- 1995-03-24 US US08/410,259 patent/US5610172A/en not_active Expired - Lifetime
- 1995-03-24 CA CA002145476A patent/CA2145476A1/en not_active Abandoned
- 1995-03-24 JP JP7065925A patent/JPH07278109A/ja active Pending
- 1995-03-25 KR KR1019950006803A patent/KR950032124A/ko not_active Application Discontinuation
-
1997
- 1997-09-24 GR GR970402504T patent/GR3024860T3/el unknown
-
1998
- 1998-12-15 HK HK98113425A patent/HK1012338A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GR3024860T3 (en) | 1998-01-30 |
| DE59500488D1 (de) | 1997-09-18 |
| US5610172A (en) | 1997-03-11 |
| AU689199B2 (en) | 1998-03-26 |
| CZ73395A3 (en) | 1995-11-15 |
| HU9500865D0 (en) | 1995-05-29 |
| PL180042B1 (en) | 2000-12-29 |
| EP0673931A1 (de) | 1995-09-27 |
| HUT72059A (en) | 1996-03-28 |
| ES2105798T3 (es) | 1997-10-16 |
| CA2145476A1 (en) | 1995-09-26 |
| ATE156815T1 (de) | 1997-08-15 |
| FI951386A0 (fi) | 1995-03-23 |
| PL307848A1 (en) | 1995-10-02 |
| NO951146D0 (no) | 1995-03-24 |
| FI951386A (fi) | 1995-09-26 |
| CZ287768B6 (en) | 2001-01-17 |
| NO951146L (no) | 1995-09-26 |
| AU1504295A (en) | 1995-10-05 |
| ZA952408B (en) | 1995-11-27 |
| NZ270783A (en) | 1997-02-24 |
| JPH07278109A (ja) | 1995-10-24 |
| NO304308B1 (no) | 1998-11-30 |
| HK1012338A1 (en) | 1999-07-30 |
| KR950032124A (ko) | 1995-12-20 |
| CN1114312A (zh) | 1996-01-03 |
| DE4410423A1 (de) | 1995-09-28 |
| EP0673931B1 (de) | 1997-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0673931T3 (da) | Sulfonamidocarbonylpyridin-2-carboxylsyreamider samt deres pyridin-N-oxider, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel | |
| NO951149D0 (no) | Sulfonamidokarbonylpyridin-2-karboksylsyreesteramider samt deres pyridin-N-oksyd, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddel | |
| ZA903804B (en) | A method of potentiating cell-mediated immunity utilizing polyamine derivatives | |
| IL109547A0 (en) | Substituted pyrroles, their preparation and pharmaceutical compositions containing them | |
| PT84814A (en) | 3-hydroxypyridines | |
| ZA905799B (en) | Control of scale in aqueous systems using certain phosphonomethyl amine oxides | |
| JPH0481594B2 (fi) | ||
| PL312240A1 (en) | Novel 3-alkoxycarbonyl-thiadiazinones, method of obtaining them and pharmaceutical preparation and method of obtaining same | |
| HUT45255A (en) | Process for producing furo/3,4-b/pyridine derivatives and pharmaceutical compositions comprising these compounds | |
| HK68295A (en) | Process for the preparation of cephalosporin derivatives | |
| ES8604583A1 (es) | Procedimiento para preparar derivados de 4,5,6,7-tetrahidro-furo- 0 1h-pirrolo-(2,3-c)piridina | |
| ES525010A0 (es) | Un metodo de preparar una forma solida, estable y soluble en agua de 3-desazaguanina | |
| HUT48893A (en) | Process for producing new cepheme derivatives |